Abstract
Twenty-three depressed patients with an average age of 78.86 were treated with trazodone in dosages averaging 354.3 mg/day. Despite pretreatment cardiac conduction delay in 30%, no electrocardiographic abnormalities were produced or exaggerated during the study. Plasma steady state levels averaged 1,474.4 ng/ml and significantly correlated with dosage at r = 0.415. In a subgroup of 13 patients, six who sustained good short-term response to trazodone had lower mean steady state plasma levels than seven who did not, suggesting that plasma levels about 1,500 ng/ml may not be therapeutic in the short run.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
